News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
304,945 Results
Type
Article (30210)
Company Profile (106)
Press Release (274629)
Multimedia
Podcasts (22)
Webinars (3)
Section
Business (79787)
Career Advice (285)
Deals (12150)
Drug Delivery (44)
Drug Development (47418)
Employer Resources (38)
FDA (6482)
Job Trends (6487)
News (144141)
Policy (11815)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (3)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (1)
2026 Biotech Bay Standard (1)
Academia (2035)
Academic (1)
Accelerated approval (3)
Adcomms (17)
Allergies (17)
Alliances (24441)
ALS (37)
Alzheimer's disease (656)
Antibody-drug conjugate (ADC) (142)
Approvals (6506)
Artificial intelligence (150)
Autoimmune disease (11)
Automation (5)
Bankruptcy (96)
Best Places to Work (5617)
BIOSECURE Act (15)
Biosimilars (46)
Biotechnology (87)
Bladder cancer (83)
Brain cancer (29)
Breast cancer (303)
Cancer (2374)
Cardiovascular disease (56)
Career advice (265)
Career pathing (7)
CAR-T (141)
Cell therapy (321)
Cervical cancer (21)
Clinical research (37622)
Collaboration (498)
Compensation (173)
Complete response letters (10)
COVID-19 (1358)
CRISPR (23)
C-suite (123)
Cystic fibrosis (33)
Data (1298)
Decentralized trials (1)
Denatured (2)
Depression (6)
Diabetes (73)
Diagnostics (3928)
Digital health (4)
Diversity (4)
Diversity, equity & inclusion (13)
Drug discovery (66)
Drug pricing (44)
Drug shortages (4)
Duchenne muscular dystrophy (21)
Earnings (25573)
Editorial (12)
Employer branding (5)
Employer resources (34)
Events (48039)
Executive appointments (328)
FDA (7067)
Featured Employer (15)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (435)
Gene editing (44)
Generative AI (8)
Gene therapy (132)
GLP-1 (232)
Government (1894)
Guidances (21)
Healthcare (9147)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (53)
Indications (19)
Infectious disease (1413)
Inflammatory bowel disease (64)
Inflation Reduction Act (4)
Influenza (17)
Intellectual property (42)
Interviews (29)
IPO (6372)
IRA (23)
Job creations (1131)
Job search strategy (248)
Kidney cancer (11)
Labor market (10)
Layoffs (193)
Leadership (2)
Legal (1979)
Liver cancer (80)
Lung cancer (344)
Lymphoma (146)
Machine learning (5)
Management (11)
Manufacturing (116)
MASH (27)
Medical device (3680)
Medtech (3680)
Mergers & acquisitions (6031)
Metabolic disorders (181)
Multiple sclerosis (24)
NASH (5)
Neurodegenerative disease (20)
Neuropsychiatric disorders (5)
Neuroscience (824)
NextGen: Class of 2025 (2695)
Non-profit (2691)
Northern California (1349)
Now hiring (7)
Obesity (81)
Opinion (98)
Ovarian cancer (78)
Pain (30)
Pancreatic cancer (85)
Parkinson's disease (47)
Partnered (11)
Patents (89)
Patient recruitment (66)
Peanut (10)
People (25688)
Pharmaceutical (23)
Pharmacy benefit managers (4)
Phase I (13572)
Phase II (16533)
Phase III (11438)
Pipeline (633)
Policy (73)
Postmarket research (1315)
Preclinical (5966)
Press Release (28)
Prostate cancer (113)
Psychedelics (13)
Radiopharmaceuticals (237)
Rare diseases (157)
Real estate (1984)
Recruiting (15)
Regulatory (8990)
Reports (17)
Research institute (2082)
Resumes & cover letters (21)
Rett syndrome (1)
RNA editing (3)
RSV (16)
Schizophrenia (19)
Series A (65)
Series B (31)
Sickle cell disease (31)
Southern California (1080)
Special edition (3)
Spinal muscular atrophy (51)
Sponsored (8)
Startups (1776)
State (1)
Stomach cancer (16)
Supply chain (18)
Tariffs (11)
The Weekly (20)
United States (10961)
Vaccines (350)
Venture capitalists (17)
Weight loss (40)
Women's health (17)
Worklife (4)
Date
Today (66)
Last 7 days (491)
Last 30 days (1357)
Last 365 days (16241)
2025 (5198)
2024 (17447)
2023 (19765)
2022 (25768)
2021 (27153)
2020 (24551)
2019 (20304)
2018 (15107)
2017 (15131)
2016 (14665)
2015 (17068)
2014 (12827)
2013 (10438)
2012 (10638)
2011 (11040)
2010 (10197)
Location
Africa (295)
Alabama (36)
Alaska (4)
Arizona (81)
Arkansas (5)
Asia (20599)
Australia (3945)
California (2912)
Canada (887)
China (349)
Colorado (132)
Connecticut (142)
Delaware (99)
Europe (42773)
Florida (414)
Georgia (74)
Idaho (20)
Illinois (255)
India (15)
Indiana (136)
Iowa (5)
Japan (86)
Kansas (36)
Kentucky (18)
Louisiana (1)
Maine (12)
Maryland (394)
Massachusetts (2115)
Michigan (49)
Minnesota (136)
Missouri (46)
Montana (14)
Nebraska (9)
Nevada (12)
New Hampshire (39)
New Jersey (959)
New Mexico (11)
New York (985)
North Carolina (347)
North Dakota (4)
Northern California (1349)
Ohio (85)
Oklahoma (6)
Oregon (13)
Pennsylvania (537)
Puerto Rico (5)
Rhode Island (11)
South America (383)
South Carolina (6)
Southern California (1080)
Tennessee (28)
Texas (579)
Utah (69)
Virginia (58)
Washington D.C. (41)
Washington State (348)
West Virginia (2)
Wisconsin (37)
304,945 Results for "huntsman cancer institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HUNTSMAN CANCER INSTITUTE BREAKS GROUND ON COMPREHENSIVE CANCER CENTER IN VINEYARD: EXPANDING ACCESS TO WORLD-CLASS CANCER CARE AND LIFESAVING RESEARCH TO MORE UTAH COMMUNITIES
April 11, 2025
·
8 min read
Press Releases
Kairos Pharma Adds Huntsman Cancer Institute for Phase 2 ENV105 Clinical Trial
February 12, 2025
·
3 min read
BioMidwest
Huntsman Cancer Institute Expands Lifesaving Impact across Utah with Plans for New Comprehensive Cancer Center
Huntsman Cancer Institute at the University of Utah, a pioneering innovator dedicated to developing more effective ways to care for and prevent cancer, announced plans for a new Huntsman Cancer Institute comprehensive cancer center in Utah County.
June 22, 2023
·
12 min read
Lone Star Bio
United Imaging Confirms Installation of Country’s First uMI Panorama™ at Huntsman Cancer Institute
United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced that The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute, part of the University of Utah health care system in Salt Lake City, has installed another United Imaging PET/CT scanner.
September 7, 2023
·
2 min read
Press Releases
Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
April 21, 2025
·
4 min read
Press Releases
Parker Institute Appoints Renowned Cancer Immunologist Dr. Ira Mellman as President of Research
April 10, 2025
·
4 min read
Press Releases
Hoag Recruits Transformative Leader, Steven Grossman, M.D. Ph.D., to Lead the Hoag Family Cancer Institute
April 28, 2025
·
4 min read
Press Releases
Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy
April 1, 2025
·
7 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
Bladder cancer
Pfizer’s Subcutaneous PD-1 Cuts Risks in Bladder Cancer but Misses Survival Endpoint
Pfizer’s sasanlimab, when used with standard of care, reduced the likelihood of disease recurrence or progression, death due to any cause or persistence of cancer cells by 32% in patients with high-risk non-muscle invasive bladder cancer.
April 28, 2025
·
1 min read
·
Tristan Manalac
1 of 30,495
Next
